JP2013047264A5 - - Google Patents

Download PDF

Info

Publication number
JP2013047264A5
JP2013047264A5 JP2012243686A JP2012243686A JP2013047264A5 JP 2013047264 A5 JP2013047264 A5 JP 2013047264A5 JP 2012243686 A JP2012243686 A JP 2012243686A JP 2012243686 A JP2012243686 A JP 2012243686A JP 2013047264 A5 JP2013047264 A5 JP 2013047264A5
Authority
JP
Japan
Prior art keywords
ceramic
particles
emulsion
diameter
biological material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012243686A
Other languages
English (en)
Other versions
JP5727445B2 (ja
JP2013047264A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013047264A publication Critical patent/JP2013047264A/ja
Publication of JP2013047264A5 publication Critical patent/JP2013047264A5/ja
Application granted granted Critical
Publication of JP5727445B2 publication Critical patent/JP5727445B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (7)

  1. 前記セラミック粒子は、直径1〜50nmの平均孔径サイズを有し、平均粒子サイズが0.05〜500ミクロンであり、直径5〜500nmの一次粒子の凝集体を含み、
    前記セラミック粒子は、凝集剤をエマルションに加えることなく、セラミック前駆物質及び生物学的物質を含む極性相が非極性相中に分散された乳液から、前記一次粒子を凝集させることによって形成され、前記セラミック粒子は残余の凝集剤フリーである、放出可能な生物学的物質を含むセラミック粒子。
  2. 前記一次粒子の直径が5〜100nmである、請求項1記載のセラミック粒子。
  3. 前記セラミック粒子は、直径1〜10nmの平均孔径サイズを有する、請求項1又は2記載のセラミック粒子。
  4. a)非極性溶媒に溶解した界面活性剤の溶液を、前記セラミック前駆物質および生物学的物質と混合して、乳液を形成すること;及び
    b)生物学的物質を含むセラミック粒子を形成するために、前記乳液中に凝集剤を添加することなく、前記乳液中で前記一次粒子を凝集させること;を含み、
    前記セラミック前駆物質は、直径が5〜500nmの一次粒子を含むゾルであるセラミック前駆体を含む、請求項1〜3のいずれかに記載のセラミック粒子。
  5. 生物学的物質がタンパク質を含む請求項1〜4のいずれかに記載セラミック粒子。
  6. 生物学的物質が、粒子全体に渡って実質的に均一に分布している請求項1〜5のいずれかに記載セラミック粒子。
  7. 生物学的物質が、粒子から放出された後でも生物学的に活性を持つ請求項1〜6のいずれかに記載セラミック粒子。
JP2012243686A 2004-12-20 2012-11-05 生物学的物質の調節放出 Expired - Fee Related JP5727445B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004907219A AU2004907219A0 (en) 2004-12-20 Controlled release of biological entities
AU2004907219 2004-12-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008518535A Division JP5593030B2 (ja) 2004-12-20 2005-12-20 生物学的物質の調節放出

Publications (3)

Publication Number Publication Date
JP2013047264A JP2013047264A (ja) 2013-03-07
JP2013047264A5 true JP2013047264A5 (ja) 2013-04-18
JP5727445B2 JP5727445B2 (ja) 2015-06-03

Family

ID=36601253

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008518535A Expired - Fee Related JP5593030B2 (ja) 2004-12-20 2005-12-20 生物学的物質の調節放出
JP2012243686A Expired - Fee Related JP5727445B2 (ja) 2004-12-20 2012-11-05 生物学的物質の調節放出

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008518535A Expired - Fee Related JP5593030B2 (ja) 2004-12-20 2005-12-20 生物学的物質の調節放出

Country Status (10)

Country Link
US (2) US8992986B2 (ja)
EP (1) EP1838289B1 (ja)
JP (2) JP5593030B2 (ja)
KR (1) KR20070104563A (ja)
CN (1) CN101106978A (ja)
BR (1) BRPI0519139A2 (ja)
CA (1) CA2591344C (ja)
MX (1) MX2007007373A (ja)
NZ (1) NZ556082A (ja)
WO (1) WO2006066317A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6101683A (en) 1998-04-02 2000-08-15 Avery Dennison Corporation Loop fastener, fastener clip including same and loop fastener dispensing tool
WO2009132411A1 (en) * 2008-04-28 2009-11-05 The University Of British Columbia Polymer-free drug delivery system for implantable medical devices
NZ595185A (en) * 2009-03-27 2012-11-30 Australian Nuclear Science Tec Triggered release of a compound or composition into solution using porus particles
KR20190006576A (ko) * 2010-08-16 2019-01-18 오스트레일리안 뉴클리어 사이언스 앤드 테크놀로지 오가니제이션 생체분자의 전달을 위한 세라믹 입자를 포함하는 미립자 물질 및 미립자 물질을 포함하는 약학적 조성물
US10001501B2 (en) 2015-12-31 2018-06-19 Universal Diagnostics, S. L. Systems and methods for automated, customizable sample preparation for detection of metabolites and lipids
CN107522868B (zh) * 2017-10-16 2021-01-08 湖北工业大学 环氧纳米二氧化硅/嵌段聚合物复合乳液的制备方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850751A (en) * 1973-02-16 1974-11-26 Corning Glass Works Enzymes immobilized on porous inorganic support materials
CH624011A5 (ja) * 1977-08-05 1981-07-15 Battelle Memorial Institute
CA1253129A (en) * 1984-02-09 1989-04-25 Thomas R. Jones Porous inorganic materials
JPH0717371B2 (ja) * 1986-09-05 1995-03-01 株式会社資生堂 球状の有機複合粘土鉱物及びその製造法
JPH05261274A (ja) 1992-03-23 1993-10-12 Lion Corp 金属化合物の球形粒子の製造方法
JP3310291B2 (ja) 1992-08-13 2002-08-05 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 骨組織のin vitro合成のための生物活性物質テンプレート
US5817327A (en) 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
US5972384A (en) 1997-10-01 1999-10-26 University Of Maryland, Baltimore Use of biologically active glass as a drug delivery system
ES2382536T3 (es) 1998-08-13 2012-06-11 Sol-Gel Technologies Ltd. Procedimiento de preparación de microcápsulas de óxido cargadas con moléculas funcionales y productos obtenidos a partir de las mismas
IL138990A0 (en) 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
WO2001001139A2 (en) 1999-06-24 2001-01-04 Mcmaster University Incorporation and appliations of biomolecular interactions within a carrier
JP2001038193A (ja) * 1999-07-28 2001-02-13 Nippon Millipore Kk 複合シリカマイクロカプセルの製造方法と複合シリカマイクロカプセルの芯物質の固定化と徐放作用の制御方法。
EP1202745A4 (en) 1999-08-16 2004-09-22 Henceforth Hibernia Inc THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS CONTAINING CATALYTIC BIOMIMETIC SOLIDS AND METHODS OF PREPARING AND USING SAME
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US6303290B1 (en) 2000-09-13 2001-10-16 The Trustees Of The University Of Pennsylvania Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US6596262B2 (en) 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6485707B2 (en) 2001-02-15 2002-11-26 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6544497B2 (en) 2001-02-15 2003-04-08 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2465779A1 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions for sustained action product delivery
US7399495B2 (en) 2002-04-30 2008-07-15 Solae, Llc Protein product imparting high water dispersibility
JP4192235B2 (ja) * 2002-04-30 2008-12-10 独立行政法人産業技術総合研究所 徐放機能を有するメソポーラス無機材料
KR20050089961A (ko) * 2002-10-11 2005-09-09 벡투라 리미티드 유기 폴리머 물질과 결합된 무기 입자들을 포함하고 고형의망상형 매트릭스를 형성하는 약학적 부형제, 조성물, 그의제조 및 용도
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
JP2005307120A (ja) * 2004-04-26 2005-11-04 Mitsubishi Chemicals Corp 徐放剤及びそれを用いた徐放材
KR20070097439A (ko) * 2004-11-15 2007-10-04 오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 마이크로에멀션의 제어된 비안정화로부터 제조된 고형분입자
US20090098044A1 (en) * 2004-11-15 2009-04-16 Australian Nuclear Science And Technology Organisation Solid particles from controlled destabilisation of microemulsions

Similar Documents

Publication Publication Date Title
JP2013047264A5 (ja)
JP2013528829A5 (ja)
JP2012072194A5 (ja)
EA201201679A1 (ru) Стабилизированная химическая композиция
JP2015519403A5 (ja)
JP2015191199A5 (ja)
JP2010506699A5 (ja)
WO2012051426A3 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
JP2009079207A5 (ja)
TN2016000512A1 (en) Amphiphilic magnetic nanoparticles and aggregates to remove hydrocarbons and metal ions and synthesis thereof
JP2011500885A5 (ja)
JP2010539337A5 (ja)
JP2012021007A5 (ja)
JP2014522375A5 (ja)
WO2013016080A3 (en) Crosslinked organic porous particles
EA201591826A1 (ru) Тонкодисперсные сухие композиции ретиноидного активного средства и содержащие их составы для местного применения
WO2015138928A3 (en) Mixed mode ligands
NZ606493A (en) Particulate substances comprising ceramic particles for delivery of biomolecules
JP2014500802A5 (ja)
JP2013142155A5 (ja)
JP2007518780A5 (ja)
RU2015145015A (ru) Способ получения водно-солевых дисперсий фуллерена
JP2017210460A5 (ja)
JP2010533313A5 (ja)
JP2014201741A5 (ja)